These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27775389)

  • 1. Immune response in virus model structured by cell infection-age.
    Browne C
    Math Biosci Eng; 2016 Oct; 13(5):887-909. PubMed ID: 27775389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of virus and immune response in multi-epitope network.
    Browne CJ; Smith HL
    J Math Biol; 2018 Dec; 77(6-7):1833-1870. PubMed ID: 29476197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global properties of nested network model with application to multi-epitope HIV/CTL dynamics.
    Browne C
    J Math Biol; 2017 Oct; 75(4):1025-1046. PubMed ID: 28220205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics.
    Yang Y; Ganusov VV
    Front Immunol; 2018; 9():140. PubMed ID: 29472921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
    Ganusov VV
    Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
    Guo T; Qiu ZP
    Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral dynamics model with CTL immune response incorporating antiretroviral therapy.
    Wang Y; Zhou Y; Brauer F; Heffernan JM
    J Math Biol; 2013 Oct; 67(4):901-34. PubMed ID: 22930342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical analysis of an age-structured HIV-1 infection model with CTL immune response.
    Tian XH; Xu R; Lin JZ
    Math Biosci Eng; 2019 Aug; 16(6):7850-7882. PubMed ID: 31698644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hopf bifurcation in a CTL-inclusive HIV-1 infection model with two time delays.
    Wang J; Qin CY; Chen YM; Wang X
    Math Biosci Eng; 2019 Mar; 16(4):2587-2612. PubMed ID: 31137229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
    Wodarz D; Nowak MA
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of an adaptive immunity viral infection model with multi-stages of infected cells and two routes of infection.
    AlShamrani NH; Elaiw AM
    Math Biosci Eng; 2019 Oct; 17(1):575-605. PubMed ID: 31731366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
    Wodarz D; Levy DN
    Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.
    Bennett MS; Ng HL; Dagarag M; Ali A; Yang OO
    J Virol; 2007 May; 81(10):4973-80. PubMed ID: 17329324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and Hopf Bifurcation in a Delayed HIV Infection Model with General Incidence Rate and Immune Impairment.
    Li F; Ma W; Jiang Z; Li D
    Comput Math Methods Med; 2015; 2015():206205. PubMed ID: 26413141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.
    Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE
    Stem Cells; 2000; 18(4):230-44. PubMed ID: 10924089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.